EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tectorigenin inhibits inflammatory responses in murine inflammatory bowel disease and LPS‐stimulated macrophages via inactivating MAPK signaling pathway

Hong Huang, Sanhui Tang, Yanghong Zhou, Yi Cai iD

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Hong Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of TCM and Integrated TCM and Western Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal Universi…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Inflammatory Bowel Diseases, MAP Kinase Signaling System, Macrophages. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Considering the antihepatitis effects of Tectorigenin (TEC), and the same adenosine mitogen‐activated protein kinase (MAPK) pathway in both hepatitis and inflammatory bowel disease (IBD) models, exploring the role of TEC in IBD is contributive to develop a new treatment strategy against IBD.

Methods

The IBD mouse model was constructed by feeding with dextran sodium sulfate (DSS) and injection of TEC. Afterward, the mouse body weight, colon length, and disease activity index (DAI) were tested to assess the enteritis level. Mouse intestine lesions were detected by hematoxylin and eosin staining. Murine macrophages underwent lipopolysaccharide (LPS) induction to establish an inflammation model. Cell viability was determined by cell counting kit‐8 assay. Enzyme‐linked immunosorbent assay was performed to measure interleukin 6 (IL‐6) and tumor necrosis factor‐α (TNF‐α) levels. Cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) expressions were quantified via quantitative reverse transcription polymerase chain reaction. Levels of MAPK pathway‐related proteins (p‐P38, P38, p‐Jun N‐terminal kinase (JNK), JNK, signal‐regulated kinase (ERK), p‐ERK), COX‐2 and iNOS were quantitated by Western blot.

Results

TEC improved the inflammatory response through ameliorating weight loss, shortening colon, and increasing DAI score in IBD mouse. Expressions of intestinal inflammatory factors (IL‐6, TNF‐α, iNOS and COX‐2) and MAPK pathway‐related proteins (p‐P38, p‐JNK, and p‐ERK) were increased both in DSS‐induced mouse intestinal tissue, but TEC inhibited expressions of inflammatory factors. The same increased trend was identified in LPS‐induced macrophages, but TEC improved macrophage inflammation, as evidenced by downregulation of inflammatory factors.

Conclusion

TEC mitigates IBD and LPS‐induced macrophage inflammation in mice via inhibiting MAPK signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesInflammatory Bowel DiseasesMAP Kinase Signaling SystemMacrophagesIsoflavonesAnimalsMiceDisease Models, AnimalDextran SulfateInflammationMaleMice, Inbred C57BLNitric Oxide Synthase Type II

Stichwörter der Autor:innen

IBDLPSMAPK signaling pathwaymacrophagestectorigenin

Substanzen

LipopolysaccharidestectorigeninIsoflavonesDextran SulfateNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • Department of TCM and Integrated TCM and Western Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Department of Liver and Gall Surgical, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.

ORCID-Profile: Yi Cai

Zitieren

APA

Huang, H., Tang, S., Zhou, Y., & Cai, Y. (2024). Tectorigenin inhibits inflammatory responses in murine inflammatory bowel disease and LPS‐stimulated macrophages via inactivating MAPK signaling pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1077

Vancouver

Huang H, Tang S, Zhou Y, Cai Y. Tectorigenin inhibits inflammatory responses in murine inflammatory bowel disease and LPS‐stimulated macrophages via inactivating MAPK signaling pathway. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1077

BibTeX
@article{Huang2024,
  author = {Huang, Hong and Tang, Sanhui and Zhou, Yanghong and Cai, Yi},
  title = {Tectorigenin inhibits inflammatory responses in murine inflammatory bowel disease and LPS‐stimulated macrophages via inactivating MAPK signaling pathway},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1077}
}
Kostenlos starten →